BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 8532908)

  • 1. Radiation-induced lung damage after thoracic irradiation for Hodgkin's disease: the role of fractionation.
    Dubray B; Henry-Amar M; Meerwaldt JH; Noordijk EM; Dixon DO; Cosset JM; Thames HD
    Radiother Oncol; 1995 Sep; 36(3):211-7. PubMed ID: 8532908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dose-effect relations for local functional and structural changes of the lung after irradiation for malignant lymphoma.
    Boersma LJ; Damen EM; de Boer RW; Muller SH; Roos CM; Valdés Olmos RA; van Zandwijk N; Lebesque JV
    Radiother Oncol; 1994 Sep; 32(3):201-9. PubMed ID: 7816939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term outcome of treatment for Ann Arbor stage 1 Hodgkin's disease: patterns of failure, late toxicity and second malignancies.
    Vlachaki MT; Ha CS; Hagemeister FB; Fuller LM; Rodriguez MA; Besa PC; Hess MA; Brown B; Cabanillas F; Cox JD
    Int J Radiat Oncol Biol Phys; 1997 Oct; 39(3):609-16. PubMed ID: 9336140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Late toxicity of radiotherapy in Hodgkin's disease. The role of fraction size.
    Cosset JM; Henry-Amar M; Girinski T; Malaise E; Dupouy N; Dutreix J
    Acta Oncol; 1988; 27(2):123-9. PubMed ID: 3390343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ischemic heart disease after mantlefield irradiation for Hodgkin's disease in long-term follow-up.
    Reinders JG; Heijmen BJ; Olofsen-van Acht MJ; van Putten WL; Levendag PC
    Radiother Oncol; 1999 Apr; 51(1):35-42. PubMed ID: 10386715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dosimetric comparison of three different involved nodal irradiation techniques for stage II Hodgkin's lymphoma patients: conventional radiotherapy, intensity-modulated radiotherapy, and three-dimensional proton radiotherapy.
    Chera BS; Rodriguez C; Morris CG; Louis D; Yeung D; Li Z; Mendenhall NP
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1173-80. PubMed ID: 19386423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mantle irradiation alone for pathologic stage I and II Hodgkin's disease: long-term follow-up and patterns of failure.
    Liao Z; Ha CS; Vlachaki MT; Hagemeister F; Cabanillas F; Hess M; Tucker S; Cox JD
    Int J Radiat Oncol Biol Phys; 2001 Jul; 50(4):971-7. PubMed ID: 11429225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac risk after mediastinal irradiation for Hodgkin's disease.
    Glanzmann C; Kaufmann P; Jenni R; Hess OM; Huguenin P
    Radiother Oncol; 1998 Jan; 46(1):51-62. PubMed ID: 9488128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of in-field control and late toxicity for adults with early-stage Hodgkin's disease treated with chemotherapy followed by radiotherapy.
    Chronowski GM; Wilder RB; Tucker SL; Ha CS; Younes A; Fayad L; Rodriguez MA; Hagemeister FB; Barista I; Cabanillas F; Cox JD
    Int J Radiat Oncol Biol Phys; 2003 Jan; 55(1):36-43. PubMed ID: 12504034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative assessment of radiation dose and fractionation effects on normal tissue by utilizing a novel lung fibrosis index model.
    Zhou C; Jones B; Moustafa M; Schwager C; Bauer J; Yang B; Cao L; Jia M; Mairani A; Chen M; Chen L; Debus J; Abdollahi A
    Radiat Oncol; 2017 Nov; 12(1):172. PubMed ID: 29116014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 3-D reconstruction of anterior mantle-field techniques in Hodgkin's disease survivors: doses to cardiac structures.
    Vordermark D; Seufert I; Schwab F; Kölbl O; Kung M; Angermann C; Flentje M
    Radiat Oncol; 2006 Apr; 1():10. PubMed ID: 16722610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term follow-up of patients treated with primary radiotherapy for supradiaphragmatic Hodgkin's disease at St. Jude Children's Research Hospital.
    Shah AB; Hudson MM; Poquette CA; Luo X; Wilimas JA; Kun LE
    Int J Radiat Oncol Biol Phys; 1999 Jul; 44(4):867-77. PubMed ID: 10386644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does bulky disease at diagnosis influence outcome in childhood Hodgkin's disease and require higher radiation doses? Results from the German-Austrian Pediatric Multicenter Trial DAL-HD-90.
    Dieckmann K; Pötter R; Hofmann J; Heinzl H; Wagner W; Schellong G;
    Int J Radiat Oncol Biol Phys; 2003 Jul; 56(3):644-52. PubMed ID: 12788169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulmonary reaction to upper mantle radiation therapy for Hodgkin's disease.
    do Pico GA; Wiley AL; Rao P; Dickie HA
    Chest; 1979 Jun; 75(6):688-92. PubMed ID: 436520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Influence of reduction of radiation dosage on the incidence of radiation-induced pneumonitis, pulmonary fibrosis and pericarditis after mediastinal irradiation in the treatment of lymphogranulomatosis].
    Libera T; Mücke R; Cihal S; Knauerhase H; Ziegler PG; Hamann D; Kundt G; Strietzel M
    Strahlenther Onkol; 1997 Jun; 173(6):330-4. PubMed ID: 9235640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Symptomatic coronary artery disease after mantle irradiation for Hodgkin's disease.
    King V; Constine LS; Clark D; Schwartz RG; Muhs AG; Henzler M; Hutson A; Rubin P
    Int J Radiat Oncol Biol Phys; 1996 Nov; 36(4):881-9. PubMed ID: 8960517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Results of a prospective study evaluating the effects of mantle irradiation on pulmonary function.
    Smith LM; Mendenhall NP; Cicale MJ; Block ER; Carter RL; Million RR
    Int J Radiat Oncol Biol Phys; 1989 Jan; 16(1):79-84. PubMed ID: 2912958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and toxicity of multiagent chemotherapy and low-dose involved-field radiotherapy in children and adolescents with Hodgkin's disease.
    Hudson MM; Greenwald C; Thompson E; Wilimas J; Marina N; Fairclough D; Kauffman W; Bozeman P; Mackert PW; Abromowitch M
    J Clin Oncol; 1993 Jan; 11(1):100-8. PubMed ID: 8418221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Roles of radiotherapy and smoking in lung cancer following Hodgkin's disease.
    van Leeuwen FE; Klokman WJ; Stovall M; Hagenbeek A; van den Belt-Dusebout AW; Noyon R; Boice JD; Burgers JM; Somers R
    J Natl Cancer Inst; 1995 Oct; 87(20):1530-7. PubMed ID: 7563187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiotherapy for early infradiaphragmatic Hodgkin's disease: the Australasian experience.
    Barton M; Boyages J; Crennan E; Davis S; Fisher RJ; Hook C; Johnson N; Joseph D; Khoo V; Liew KH; Morgan G; O'Brien P; Pendlebury S; Pratt G; Quong G; Roos DE; Thornton D; Trotter G; Walker Q; Wallington M
    Radiother Oncol; 1996 Apr; 39(1):1-7. PubMed ID: 8735487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.